When the NIH canceled grants in March related to diversity, equity and inclusion, or DEI, some Alzheimer’s studies were swept ...

A new study found that a gene recently recognized as a biomarker for Alzheimer's disease is actually a cause of it, due to ...

Researchers have discovered that a gene previously seen as a biomarker for Alzheimer’s disease, PHGDH, actually plays a ...

Not surprisingly, finding the magic bullet has become the holy grail for Alzheimer’s researchers. But it’s proving to be an ...

Alzheimer’s disease is commonly thought of as an older person’s illness. But new research from Columbia University and the ...

Johnson, a family friend, visited the woman’s Port Hueneme home, where she lived with her daughter in February 2020, ...

There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears to slow ...

AI model reveals the structural secrets of misfolded proteins. A new artificial intelligence (AI) tool has provided critical ...

An extended family in that South American country has a devastating genetic variant that triggers early-onset dementia. "They ...

The second U.S. drug shown to slow the progression of early Alzheimer's has arrived in Seattle-area clinics. One of the first ...

Researchers are looking for 200 healthy adults between 65 and 75 who have a close family member with dementia but who do not ...

HudsonAlpha launched a pilot study, Hope AD, to see how genetics and lifestyle influence a person’s risk of developing ...